Strategy
MSTR
MARA Holdings
MARA
Tesla
TSLA
Coinbase
COIN
Apple
AAPL
US Stock MarketDetailed Quotes
XGN Exagen
- 3.460
- -0.090-2.54%
Close Feb 28 16:00 ET
- 3.460
- 0.0000.00%
Post 16:05 ET
61.02MMarket Cap-3.68P/E (TTM)
3.670High3.310Low110.01KVolume3.520Open3.550Pre Close379.14KTurnover1.26%Turnover RatioLossP/E (Static)17.64MShares6.22052wk High4.74P/B30.16MFloat Cap1.30052wk Low--Dividend TTM8.72MShs Float29.858Historical High--Div YieldTTM10.14%Amplitude1.300Historical Low3.446Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Exagen Stock Forum
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t a...
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
Sunday, 12th January at 12:00 pm
New biomarkers on track for commercial launch in January 2025
Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn
CARLSBAD, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:...
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
No comment yet